Coldstream Capital Management Inc. Boosts Stock Position in DENTSPLY SIRONA Inc. $XRAY

Coldstream Capital Management Inc. boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 333.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,140 shares of the medical instruments supplier’s stock after acquiring an additional 15,489 shares during the quarter. Coldstream Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $320,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of XRAY. Bank of Montreal Can increased its stake in DENTSPLY SIRONA by 8.2% during the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock worth $5,598,000 after buying an additional 26,610 shares during the period. Envestnet Portfolio Solutions Inc. grew its stake in shares of DENTSPLY SIRONA by 36.9% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock worth $246,000 after acquiring an additional 4,165 shares in the last quarter. AGF Management Ltd. increased its position in shares of DENTSPLY SIRONA by 29.6% during the second quarter. AGF Management Ltd. now owns 186,424 shares of the medical instruments supplier’s stock worth $2,960,000 after acquiring an additional 42,542 shares during the period. Nordea Investment Management AB raised its stake in shares of DENTSPLY SIRONA by 71.0% in the second quarter. Nordea Investment Management AB now owns 428,015 shares of the medical instruments supplier’s stock valued at $6,853,000 after acquiring an additional 177,750 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at $366,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

XRAY has been the topic of several recent research reports. Zacks Research downgraded DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a report on Tuesday, October 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Two research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $16.08.

DENTSPLY SIRONA Trading Up 0.4%

Shares of DENTSPLY SIRONA stock opened at $11.34 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The company has a fifty day simple moving average of $12.05 and a 200-day simple moving average of $14.11. The stock has a market cap of $2.26 billion, a price-to-earnings ratio of -2.39, a PEG ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 12-month low of $9.85 and a 12-month high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The company had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA’s revenue was down 4.9% on a year-over-year basis. During the same period last year, the firm earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.